Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck.
Authors:
- J E ByfieldJBJ E Byfield
- T R SharpTST R Sharp
- S S FrankelSFS S Frankel
- S G TangSTS G Tang
- F B CallipariFCF B Callipari
- 1 May 1984
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 2 (5) , 406-413
Abstract
Eighteen patients with advanced epithelial cancers of the head and neck region were studied for their tolerance and response to combined cycles of 120-hour infused 5-fluorouracil (5-FU) and external-beam radiation therapy. 5-FU infusions were given under conditions where radiosensitization would be expected at the higher infusion doses. Coincident radiation treatments were given as four sequential daily fractions of 250 rad each administered during days 1 through 4 of each five-day infusion cycle. The patients were rested for at least nine days after each cycle or longer until toxicity was resolved. The regimen was then repeated in each patient for a total of five treatment cycles. Thereafter therapy was consolidated, usually by boost radiation without drug. In sequential patient subsets the infusion load was progressively escalated in a phase I format. The complete response rate for stage IV patients was 75% with survival benefit compared to prior results. 5-FU dose-dependent combined modality loco-regional toxicity was demonstrated without significant enhancement of systemic toxicity of any form; 5-FU dose-dependent enhanced responsiveness and survival benefit is also suggested. Further scheduling and response studies of 5-FU under radiosensitizing conditions appear warranted.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Clearance of Continuously Infused 5-Fluorouracil in Adults Having Lung or Gastrointestinal Carcinoma with or without Hepatic MetastasesDrug Intelligence & Clinical Pharmacy, 1982
- Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastasesCancer, 1982
- TIME-DOSE RELATIONSHIPS FOR 5-FLUOROURACIL CYTO-TOXICITY AGAINST HUMAN EPITHELIAL CANCER-CELLS INVITRO1982
- Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancerCancer, 1980
- ADVERSE EFFECT OF RADIOTHERAPY ON ADJUVANT CHEMOTHERAPY FOR CARCINOMA OF THE BREAST1980
- PHARMACOKINETICS OF 5-FLUOROURACIL ADMINISTERED ORALLY, BY RAPID INTRAVENOUS AND BY SLOW INFUSION1980
- Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusionBritish Journal of Cancer, 1978